Follow
David Ridley
Title
Cited by
Cited by
Year
Developing drugs for developing countries
DB Ridley, HG Grabowski, JL Moe
Health Affairs 25 (2), 313-324, 2006
2572006
Entry and competition in generic biologics
HG Grabowski, DB Ridley, KA Schulman
Managerial and Decision Economics 28 (4‐5), 439-451, 2007
952007
Distance decreases with differentiation: Strategic agglomeration by retailers
GA Picone, DB Ridley, PA Zandbergen
International Journal of Industrial Organization 27 (3), 463-473, 2009
922009
Pharmaceutical followers
P Arcidiacono, PB Ellickson, P Landry, DB Ridley
International Journal of Industrial Organization 31 (5), 538-553, 2013
902013
Price differentiation and transparency in the global pharmaceutical marketplace
DB Ridley
Pharmacoeconomics 23, 651-658, 2005
682005
Would greater transparency and uniformity of health care prices benefit poor patients?
MK Kyle, DB Ridley
Health Affairs 26 (5), 1384-1391, 2007
672007
The role of government reimbursement in drug shortages
A Yurukoglu, E Liebman, DB Ridley
American Economic Journal: Economic Policy 9 (2), 348-382, 2017
582017
Herding versus Hotelling: Market entry with costly information
DB Ridley
Journal of Economics & Management Strategy 17 (3), 607-631, 2008
542008
The commercial market for priority review vouchers
DB Ridley, SA Régnier
Health Affairs 35 (5), 776-783, 2016
442016
Introduction of European priority review vouchers to encourage development of new medicines for neglected diseases
DB Ridley, AC Sánchez
The Lancet 376 (9744), 922-927, 2010
362010
Impact of Medicaid preferred drug lists on therapeutic adherence
DB Ridley, KJ Axelsen
Pharmacoeconomics 24, 65-78, 2006
332006
Drugs and vaccines for developing countries
A Towse, E Keuffel, HE Kettler, DB Ridley
The Oxford handbook of the economics of the biopharmaceutical industry, 302-310, 2012
272012
No shot: US vaccine prices and shortages
DB Ridley, X Bei, EB Liebman
Health Affairs 35 (2), 235-241, 2016
252016
Priorities for the priority review voucher
DB Ridley
The American journal of tropical medicine and hygiene 96 (1), 14, 2017
242017
Retail zoning and competition
DB Ridley, FA Sloan, Y Song
Working Paper, 2010
242010
Strategic interaction among governments in the provision of a global public good
MK Kyle, DB Ridley, S Zhang
Journal of Public Economics 156, 185-199, 2017
192017
Forecasting market share in the US pharmaceutical market
S Regnier, DB Ridley
nature reviews drug discovery 14 (9), 594-595, 2015
182015
The cost of inefficiency in US hospitals, 1985-1997.
BR Shah, SD Reed, J Francis, DB Ridley, KA Schulman
Journal of Health Care Finance 30 (1), 1-9, 2003
182003
Spending on postapproval drug safety
DB Ridley, JM Kramer, HH Tilson, HG Grabowski, KA Schulman
Health Affairs 25 (2), 429-436, 2006
172006
Payments, promotion, and the purple pill
DB Ridley
Health economics 24 (1), 86-103, 2015
162015
The system can't perform the operation now. Try again later.
Articles 1–20